Study of Calcium Metabolism in Teenage Girls With Type 1 Diabetes
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Diagnostic Test: calcium isotope analysis
- Registration Number
- NCT03156179
- Lead Sponsor
- University of Rochester
- Brief Summary
The proposed pilot study will enroll 33 adolescent females with type 1 diabetes for the assessment of whole body calcium metabolism using dual stable calcium isotopes. This is the state of the art technique for assessing calcium metabolism in the body and has been used in both healthy and diseased pediatric populations.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 22
- Diagnosis of T1D of at least three years duration
- Female sex
- Age between 9-18 years
- Parental/guardian consent and participant assent
- BMI <99th percentile
- History of metabolic bone disease, chronic renal disease, hepatic disease, celiac, or other malabsorptive disease
- History of any proton-pump inhibitor use within a 6 month period prior to enrollment
- History of oral or inhaled corticosteroid use for ≥ 5 consecutive days within a 6 month period prior to enrollment
- Pregnant or lactating females
- Parents/guardians or participants who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Girls with type 1 diabetes calcium isotope analysis -
- Primary Outcome Measures
Name Time Method fractional calcium absorption 24 hours Mass spectroscopy was performed using urine to measure the stable calcium isotope. Percent dietary calcium absorption was calculated as the ratio of the cumulative recovery of 44Ca (oral tracer) to the cumulative recovery of 42Ca (IV tracer) in the 24-hour urine sample.
- Secondary Outcome Measures
Name Time Method Estimated calcium retention 24 hours Gastrointestinal calcium absorption minus the total of urine calcium excretion and estimated stool calcium excretion.
Trial Locations
- Locations (1)
Univeristy of Rochester Medical Center
🇺🇸Rochester, New York, United States